Literature DB >> 33717327

The Shortage of Malaysian Stem Cell Ethics in Mainstream Database: a Preliminary Study.

Gopalan Nishakanthi1.   

Abstract

Ethics is a philosophical branch of inquiry that reasons between what is right and wrong. The moral philosophy of Socrates, Aristotle, and Plato from ancient Greek became the basis of most of the western ethics. These days, ethics can be divided based on its inquiries for example, normative, descriptive, metaethics, and applied ethics or based on its theories like utilitarianism, emotivism, and universal ethics. In context with applied ethics that examines issues involving emerging technologies, this study will look into the ethics of Malaysian stem cell technology based on written literature. It was mainly to identify Malaysian literature on stem cell ethics through conventional search since the mainstream international database indicated an obvious shortage. The critical review of this literature will facilitate in the understanding of unique position of Malaysia towards stem cell and its ethics in reference to the limited number. Despite the limitation, this can be a preliminary study urging for more inquiries and exploration to fulfil the multiple perspectives in ethics such as the diversity of Malaysian ethics, the impact of ethics in stem cell regulation in Malaysia, and if western contemporary ethics influences Malaysian ethics particularly involving stem cell technology. © National University of Singapore and Springer Nature Singapore Pte Ltd. 2019.

Keywords:  Ethical perspective; Islamic ethics; Relativism; Religious ethics; Stem cell technology; Universalism

Year:  2019        PMID: 33717327      PMCID: PMC7747286          DOI: 10.1007/s41649-019-00102-5

Source DB:  PubMed          Journal:  Asian Bioeth Rev        ISSN: 1793-9453


  30 in total

Review 1.  Ethical decision-making models: a review of the literature.

Authors:  R R Cottone; R E Claus
Journal:  J Couns Dev       Date:  2000

2.  International stem cell tourism and the need for effective regulation. Part I: Stem cell tourism in Russia and India: clinical research, innovative treatment, or unproven hype?

Authors:  Cynthia B Cohen; Peter J Cohen
Journal:  Kennedy Inst Ethics J       Date:  2010-03

3.  Human Embryonic Stem Cell Research: Ethical Views of Buddhist, Hindu and Catholic Leaders in Malaysia.

Authors:  Mathana Amaris Fiona Sivaraman; Siti Nurani Mohd Noor
Journal:  Sci Eng Ethics       Date:  2015-06-07       Impact factor: 3.525

Review 4.  Regulation of Stem Cell Technology in Malaysia: Current Status and Recommendations.

Authors:  Nishakanthi Gopalan; Siti Nurani Mohd Nor; Mohd Salim Mohamed
Journal:  Sci Eng Ethics       Date:  2019-05-23       Impact factor: 3.525

Review 5.  The ethics of research biobanking: a critical review of the literature.

Authors:  Klaus Hoeyer
Journal:  Biotechnol Genet Eng Rev       Date:  2008

6.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Human embryonic stem cell (hESC) and human embryo research.

Authors:  Jessica Shand; Jessica Berg; Clifford Bogue
Journal:  Pediatrics       Date:  2012-10-29       Impact factor: 7.124

Review 9.  Marketing of unproven stem cell-based interventions: A call to action.

Authors:  Douglas Sipp; Timothy Caulfield; Jane Kaye; Jan Barfoot; Clare Blackburn; Sarah Chan; Michele De Luca; Alastair Kent; Christopher McCabe; Megan Munsie; Margaret Sleeboom-Faulkner; Jeremy Sugarman; Esther van Zimmeren; Amy Zarzeczny; John E J Rasko
Journal:  Sci Transl Med       Date:  2017-07-05       Impact factor: 17.956

Review 10.  Sourcing human embryos for embryonic stem cell lines: problems & perspectives.

Authors:  Rajvi H Mehta
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.